BBSRC Portfolio Analyser
Award details
Marek's disease virus pathogenesis and disease resistance
Reference
BBS/E/I/00001111
Principal Investigator / Supervisor
Professor Venugopal Nair
Co-Investigators /
Co-Supervisors
Institution
The Pirbright Institute
Department
The Pirbright Institute Department
Funding type
Research
Value (£)
308,156
Status
Completed
Type
Institute Project
Start date
15/06/2005
End date
13/01/2010
Duration
55 months
Abstract
Marek's disease (MD) is a highly contagious disease caused by an oncogenic alphaherpesvirus. Control of MD is currently achieved by vaccination with live attenuated vaccines. However, the emergence of more virulent strains of Marek's disease virus (MDV) has indicated that alternative strategies will be required to control this disease in the future. A key objective of this proposal is to identify genes associated with the pathogenesis and latency of MDV infection and to exploit this knowledge to develop disease resistant chickens. The strategy will involve analysing gene function using siRNA technology and generation of chickens expressing siRNA transgenically in order to define gene function during MDV infection. The investigation will focus on known transforming/latency genes such as Meq, MSRs (Marek's disease small RNAs) and ICP4 as well as characterising genes of unknown function. Meq will be used as a 'proof of principle' for siRNA disruption of viral oncogenesis in transgenic chickens.
Summary
unavailable
Committee
Closed Committee - Animal Sciences (AS)
Research Topics
Animal Health, Immunology, Microbiology
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search